Seroprevalence as an Indicator of Undercounting of COVID-19 Cases in a Large Well-Described Cohort by Kevin M. Taylor, MD, Keersten M. Ricks, PhD, Paul A. Kuehnert, MS, Angelia A. Eick-Cost, PhD, Mark R. Scheckelhoff, PhD, Andrew R. Wiesen, MD, Tamara L. Clements, MS, Zheng Hu, MS, Samantha E. Zak, MS, Scott P. Olschner, BS, Andrew S. Herbert, PhD, Sara L. Bazaco, PhD, Kathleen E. Creppage, DrPH, Michael T. Fan, PhD, Jose L. Sanchez, MD

Get full text